Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see what dose of the drug cidofovir is safe to treat
laryngeal papillomatosis (warts in the throat which occur over and over) in children.
Laryngeal papillomatosis is caused by infection with a virus called human papillomavirus
(HPV). At present, there is no approved drug to treat this infection. However, cidofovir is a
drug effective against several viruses. Cidofovir may be able to attack the HPV virus. This
study tests the safety of giving this drug to children.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)